Zentalis Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ZNTL and other ETFs, options, and stocks.About ZNTL
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations.
CEOJulia Marie Eastland
CEOJulia Marie Eastland
Employees166
Employees166
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2014
Founded2014
Employees166
Employees166
ZNTL Key Statistics
Market cap102.43M
Market cap102.43M
Price-Earnings ratio-0.64
Price-Earnings ratio-0.64
Dividend yield—
Dividend yield—
Average volume613.85K
Average volume613.85K
High today$1.47
High today$1.47
Low today$1.40
Low today$1.40
Open price$1.45
Open price$1.45
Volume594.53K
Volume594.53K
52 Week high$5.44
52 Week high$5.44
52 Week low$1.01
52 Week low$1.01
Analyst ratings
56%
of 9 ratingsBuy
44.4%
Hold
55.6%
Sell
0%
People also own
Based on the portfolios of people who own ZNTL. This list is generated using Robinhood data, and it’s not a recommendation.